Altamira Therapeutics Ltd.

The momentum for this stock is not very good. Altamira Therapeutics Ltd. is not very popular among insiders. Tradey thinks it is not wise to invest in Altamira Therapeutics Ltd..

News

Altamira Therapeutics (NASDAQ:CYTO) Shares Up 1.8%

Zolmax Altamira Therapeutics Ltd. (NASDAQ:CYTO - Get Free Report) traded up 1.8% during trading on Tuesday . The company traded as high as $0.93 and last traded at $0.92. 14,053 shares were traded during...\n more…

Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11

Globe Newswire Hamilton, Bermuda, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company dedicated to developing and commercializing RNA delivery...\n more…

REPEAT -- Diamond Equity Research Releases Update Note on Altamira Therapeutics Ltd. (NASDAQ: CYTO)

Globe Newswire NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an update note on Altamira...\n more…

Diamond Equity Research Releases Update Note on Altamira Therapeutics Ltd. (NASDAQ: CYTO)

Altamira Therapeutics extends distribution agreement with Pharma Nordic

Seeking Alpha - Healthcare Altamira Therapeutics extends distribution agreement with Pharma Nordic...\n more…

Altamira Therapeutics announces extension of Bentrio distribution agreement

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…